Genetic Testing in Parkinson's Disease
Movement Disorders · 2023-08 · 38 (8) · 1384-1396
DOI: 10.1002/mds.29500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 27.06.2023. Verfasst von Gian Pal und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, Aligning Science Across Parkinson’s, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Genetic testing for persons with Parkinson's disease is becoming increasingly common. Significant gains have been made regarding genetic testing methods, and testing is becoming more readily available in clinical, research, and direct‐to‐consumer settings. Although the potential utility of clinical testing is expanding, there are currently no proven gene‐targeted therapies, but clinical trials are underway. Furthermore, genetic testing practices vary widely, as do knowledge and attitudes of relevant stakeholders. The specter of testing mandates financial, ethical, and physician engagement, and there is a need for guidelines to help navigate the myriad of challenges. However, to develop guidelines, gaps and controversies need to be clearly identified and analyzed. To this end, we first reviewed recent literature and subsequently identified gaps and controversies, some of which were partially addressed in the literature, but many of which are not well delineated or researched. Key gaps and controversies include: (1) Is genetic testing appropriate in symptomatic and asymptomatic individuals without medical actionability? (2) How, if at all, should testing vary based on ethnicity? (3) What are the long‐term outcomes of consumer‐ and research‐based genetic testing in presymptomatic PD? (4) What resources are needed for clinical genetic testing, and how is this impacted by models of care and cost‐benefit considerations? Addressing these issues will help facilitate the development of consensus and guidelines regarding the approach and access to genetic testing and counseling. This is also needed to guide a multidisciplinary approach that accounts for cultural, geographic, and socioeconomic factors in developing testing guidelines. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Neurology, Columbia University Irving Medical Center, New York, New York, USA.
- Movement Disorders Division, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Neuroscience Department Fleni, CONICET, Catholic University of Buenos Aires, Buenos Aires, Argentina.
- Department of Neurology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
ORCID-Profile: Gian Pal, Lola Cook, Roy N Alcalay, Marcelo Merello, Soraya Bardien, Sun Ju Chung, Mehri Salari, Niccolò E Mencacci, Rachel Saunders-Pullman
Förderung
- NINDS NIH HHS
- Aligning Science Across Parkinson’s
- Deutsche Forschungsgemeinschaft
- Michael J. Fox Foundation for Parkinson's Research
- National Institute of Neurological Disorders and Stroke
- Parkinson's Foundation
- South African Medical Research Council
Zitieren
APA
Pal, G., Cook, L., Schulze, J., Verbrugge, J., Alcalay, R. N., Merello, M., Sue, C. M., Bardien, S., Bonifati, V., Chung, S. J., Foroud, T., Gatto, E., Hall, A., Hattori, N., Lynch, T., Marder, K., Mascalzoni, D., Novaković, I., Thaler, A., …, & Klein, C. (2023). Genetic Testing in Parkinson's Disease. Movement Disorders, 38(8), 1384-1396. https://doi.org/10.1002/mds.29500
Vancouver
Pal G, Cook L, Schulze J, Verbrugge J, Alcalay RN, Merello M, et al. Genetic Testing in Parkinson's Disease. Movement Disorders. 2023;38(8):1384-1396. doi:10.1002/mds.29500
BibTeX
@article{Pal2023,
author = {Pal, Gian and Cook, Lola and Schulze, Jeanine and Verbrugge, Jennifer and Alcalay, Roy N and Merello, Marcelo and Sue, Carolyn M and Bardien, Soraya and Bonifati, Vincenzo and Chung, Sun Ju and Foroud, Tatiana and Gatto, Emilia and Hall, Anne and Hattori, Nobutaka and Lynch, Tim and Marder, Karen and Mascalzoni, Deborah and Novaković, Ivana and Thaler, Avner and Raymond, Deborah and Salari, Mehri and Shalash, Ali and Suchowersky, Oksana and Mencacci, Niccolò E and Simuni, Tanya and Saunders-Pullman, Rachel and Klein, Christine},
title = {Genetic Testing in Parkinson's Disease},
journal = {Movement Disorders},
year = {2023},
volume = {38},
number = {8},
pages = {1384--1396},
doi = {10.1002/mds.29500}
}
EUVIMED